Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin
💡 newsR Knowledge: Other News Mentions
Maharashtra reports 67,123, Karnataka registers 17,489 COVID cases
Credit: ANI Duration: 01:22Published
Kiren Rijiju tests positive for COVID-19
Credit: ANI Duration: 01:04Published
'India defeated COVID-19 last year, can do it again': PM Modi at review meet - Key pointsPrime Minister Narendra Modi on Saturday chaired a meeting to review the status of preparedness to handle the ongoing Covid-19 pandemic.
Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccinesThe Central Drugs Standards Control Organisation (CDSCO) headed by Drugs Controller General of India (DCGI) has explained that it prepare detailed guidelines..
Sputnik V cleared for launch in India: Five things you need to know about Russian Covid-19 vaccineDr Reddy's Laboratories said on Tuesday it has received permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for..
Sputnik V cleared for launch in India: Five things you need to know about Russian vaccineFollowing the recommendation of the Drug Controller General of India (DGCI)'s subject expert committee, Russia's anti-Covid vaccine Sputnik V now awaits final..
Expert panel clears Sputnik V for ‘emergency use’, drug regulator’s nod expected soonAmid concerns about the need to step up Covid-19 vaccination, India is soon expected to get its third shot against the infection with the drug regulator’s..
Russia hopes approval to Sputnik-V vaccine by DCGI will be completed soonRussia on Monday hoped that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it..
India to increase Covaxin production to 100 million doses per month by SeptemberThe Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin
Credit: ANI Duration: 01:14Published
Even as Covid vaccine demand rises, firms may take some weeks to up productionIndications are that India’s vaccine production is expected to be limited for a few more weeks though a step-up is expected as Serum Institute of India and..
Nurses share experience after administering COVID vaccine to PM Modi
Credit: ANI Duration: 01:16Published
Covaxin production to be increased to 100 million doses per month by September 2021: CentreUnion health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
You Might Like
Related videos from verified sources
Related news from verified sources